₹ 6573
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Target Price
The average target price of DIVISLAB.NS is 6554 and suggests 0% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation
